Safety of a Candidate Bioconjugate Vaccine Against Shigella Flexneri 2a
Condition: ShigellosisInterventions: Biological: Flexyn2a; Biological: Placebo; Biological: Flexyn2a plus adjuvantSponsors: GlycoVaxyn AG; Wellcome Trust; Naval Medical Research CenterActive, not recruiting - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials